Metal complexes, their cellular targets and potential for cancer therapy.
about
A Mechanism for the Temporal Potentiation of Genipin to the Cytotoxicity of Cisplatin in Colon Cancer CellsTargeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.Activation of the MAPK11/12/13/14 (p38 MAPK) pathway regulates the transcription of autophagy genes in response to oxidative stress induced by a novel copper complex in HeLa cellsDifferent apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary cultureTumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death.Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilizationMixed ligand μ-phenoxo-bridged dinuclear copper(II) complexes with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.Impact of inhomogeneous static magnetic field (31.7-232.0 mT) exposure on human neuroblastoma SH-SY5Y cells during cisplatin administration.N-heterocyclic carbene gold(I) and silver(I) complexes bearing functional groups for bio-conjugation.Mixed ligand copper(II) dicarboxylate complexes: the role of co-ligand hydrophobicity in DNA binding, double-strand DNA cleavage, protein binding and cytotoxicity.Cell-centric view of apoptosis and apoptotic cell death-inducing antitumoral strategiesNovel metals and metal complexes as platforms for cancer therapyN-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug DeliveryAnticancer activity of metal complexes: involvement of redox processes.Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs.Metal-mediated DNA damage and cell death: mechanisms, detection methods, and cellular consequences.Newly Synthesized Doxorubicin Complexes with Selected Metals-Synthesis, Structure and Anti-Breast Cancer Activity.Metal-based drugs that break the rules.In Vitro DNA-Binding, Anti-Oxidant and Anticancer Activity of Indole-2-Carboxylic Acid Dinuclear Copper(II) Complexes.Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.The gold (III) porphyrin complex, gold-2a, suppresses WNT1 expression in breast cancer cells by enhancing the promoter association of YY1.Which Metals are Green for Catalysis? Comparison of the Toxicities of Ni, Cu, Fe, Pd, Pt, Rh, and Au Salts.Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells.Synthesis, characterization, DNA interaction and cleavage, and in vitro cytotoxicity of copper(II) mixed-ligand complexes with 2-phenyl-3-hydroxy-4(1H)-quinolinone.N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell deathAnticancer activity and mode of action of titanocene C.Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender DifferencesAPI5 induces cisplatin resistance through FGFR signaling in human cancer cells.Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effectsMetal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.Selenium protects cerebral cells by cisplatin induced neurotoxicity.Cytoprotective Effects of Cell-Permeable Bifunctional Antioxidant Enzyme, GST-TAT-SOD, against Cisplatin-Induced Cell Damage.Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
P2860
Q28384202-39576A3A-38E6-42CB-A72D-FEA16C041F85Q34195083-23B20330-6BEA-4033-825D-78455FE46D76Q34373124-06709E60-1A02-4A0B-8B24-171D9BC0129AQ34619471-44F3BFD0-E8AA-42CB-A565-A8BFF8C7E409Q35040088-1910EDBC-1F62-4541-8E11-896E66392CB9Q35059923-E67A030E-609D-479B-BA6F-08A5F77C6DCFQ35111438-F93BF8E3-2024-4769-BCF6-4FF6DF527CBFQ35448703-63419134-DB93-4C68-ACA6-836D8EA6C0C5Q35504676-EC5DBECD-7A4B-4165-8C1A-5A7072871D3AQ35625019-500D3DD4-8C40-4541-AFC8-6AC47CF8A807Q37129849-26F31791-AEB0-40AB-8471-43FB2A97358BQ37137649-CD57CED5-61D4-45EA-B06A-728C8DB0A6FAQ37603242-7A3D9635-C8D3-41A6-B8CB-D16F72746EF8Q37833099-F435A53C-C4B1-4C58-84A4-A24FB0645901Q38011996-6B20AFD5-9105-4E1E-9B59-5138FE816DA4Q38208675-5ABEEA21-0544-4F60-8549-C46D5E7E9190Q38698082-6C9A0041-D47D-49FB-B86F-3ABA1E623A08Q38714812-CE0F679C-20D7-4675-9CC1-ABA02C6B1329Q38719744-EF1DAD80-EFAE-444A-9E91-A4BBF064B25FQ38863948-1E9DC7B0-BA5B-4320-A19A-49FEBE5BF9CEQ38880669-C62E2C2A-6C67-421A-9558-EFE76BA9698AQ38929495-97A465F5-7285-4370-AB83-DBA3755DD327Q39022882-0D12228D-58BC-4137-BE3A-C71B396B7725Q39470004-E8F9ABB1-492D-46EB-869B-E4F86001D17AQ39490260-CB685A96-A745-42A9-B317-3CAEADE83D40Q39674393-4484E01A-A030-47CD-9222-D72300BA7755Q39738480-03DE778C-E8F3-4E90-B242-BF7739F20E81Q42343539-FE0E2972-F18B-46F2-A55D-7EACE2221CA4Q42370427-15476083-44BC-4994-923A-614638D57DCFQ42575787-BE7D3966-3099-474C-946E-223EAA18F395Q47098444-3E448F27-7761-4BAE-A46C-197059CA19AEQ48111415-F54693F3-551C-40CA-8A9E-5A90BE6D92D7Q48247138-45D7C4B1-3DBD-495C-BC02-D3FC5DCDADFFQ48687653-98A91665-63BA-493D-9206-AE16E7CB99F4Q50063144-89085C0F-E17B-4967-A898-203CF035CD3D
P2860
Metal complexes, their cellular targets and potential for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metal complexes, their cellular targets and potential for cancer therapy.
@en
Metal complexes, their cellular targets and potential for cancer therapy.
@nl
type
label
Metal complexes, their cellular targets and potential for cancer therapy.
@en
Metal complexes, their cellular targets and potential for cancer therapy.
@nl
prefLabel
Metal complexes, their cellular targets and potential for cancer therapy.
@en
Metal complexes, their cellular targets and potential for cancer therapy.
@nl
P2093
P1476
Metal complexes, their cellular targets and potential for cancer therapy.
@en
P2093
Michael Frezza
Q Ping Dou
Vesna Milacic
P304
P356
10.2174/138161209787582183
P577
2009-01-01T00:00:00Z